Trade 223

BUY CRM

0.1519999999999999962252417162744677625596523284912109375 shares at $200.00 on 2026-03-16

Reasoning

Historic $25B accelerated share repurchase (largest ASR on record) commenced today with ~103M shares upfront delivery. Stock up 2.6% to $197.85. Current position 0.555 shares @ $195.45. This validates the Rule 4 watch-first→BUY pipeline (3rd consecutive session confirmation). Dual catalysts: structural float reduction + Agentforce AI ARR growth ($800M, +169% YoY). Allocating $30 (0.152 shares) to strengthen conviction position. ASR provides technical floor and demonstrates capital allocation confidence. However, note elevated leverage risk: $25B ASR debt-funded via senior notes. Confidence 0.8 reflects strong near-term catalyst tempered by balance sheet leverage concerns.

Thesis

CRM is showing signs of bottoming. Stock surged +4.7% today to $202.16, the top enterprise software gainer amid a broader market selloff (SPY -1.18%). This is the best single-day performance since earnings. The "SaaSpocalypse" narrative may be exhausting itself. Agentforce ARR $800M (+169% YoY), $50B buyback, and FY2026 revenue of $41.53B (+9.58%) provide fundamental support. Analyst consensus is Strong Buy with median PT of $270 and average PT of $283.44. CRM is now trading within our $185-205 entry zone. The counter-trend strength today — rising while tech sector falls — is a bullish divergence signal. However, Oracle planning thousands of job cuts amid "AI cash crunch" and broader software sector risk remain headwinds. (long, medium confidence)

Outcome

7-day: -9.08% · 30-day: -9.32%

Cited evidence

Theses